Kintor Pharmaceutical Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-200.11	-155.29	-1,061	-954.37	-842.1
Depreciation & Amortization	33.21	17.49	18.86	18.24	10.37
Other Amortization	-	0.13	0.12	0.15	0.14
Loss (Gain) From Sale of Assets	-	-2.52	-0.01	0.62	0.11
Asset Writedown & Restructuring Costs	-	13.82	134.07	-	-
Loss (Gain) From Sale of Investments	-	-0	-0.49	-2	-0.78
Loss (Gain) on Equity Investments	-	1.43	-0.05	0.57	-
Stock-Based Compensation	-	-9.11	22.99	95.64	37.35
Provision & Write-off of Bad Debts	-	1.21	-	-	-
Other Operating Activities	-2.84	-15.1	594.24	77.85	28.13
Change in Accounts Receivable	-	8.57	7.62	94.23	-86.03
Change in Inventory	-	-4.32	-0.38	-345.13	-351.36
Change in Accounts Payable	-	-49.95	-106.84	6.76	155.32
Change in Unearned Revenue	-	-	-0.3	15.94	3.65
Change in Other Net Operating Assets	-	-5.44	3.41	30.24	-6.16
Operating Cash Flow	-169.74	-199.08	-387.58	-961.26	-1,051
Capital Expenditures	-0.7	-1.54	-2.72	-27.47	-76.24
Sale of Property, Plant & Equipment	-	0.23	0.21	0.2	0.01
Sale (Purchase) of Intangibles	15.6	10.29	-	-0.18	-29.5
Investment in Securities	1.1	10	-0.85	97.84	195.53
Other Investing Activities	-1.59	1.05	6.64	-3.19	2.2
Investing Cash Flow	14.41	20.03	3.27	67.2	92.01
Long-Term Debt Issued	116.4	34.28	70	170	20
Long-Term Debt Repaid	-163.2	-154.33	-104.22	-53.01	-112.52
Net Debt Issued (Repaid)	-46.8	-120.04	-34.22	116.99	-92.52
Issuance of Common Stock	82.6	0.37	0.76	698.76	951.97
Other Financing Activities	4.47	-	-	-	-2.03
Financing Cash Flow	40.27	-119.67	-33.46	815.75	857.42
Foreign Exchange Rate Adjustments	0.38	2.11	-2.67	16.45	-36.42
Net Cash Flow	-114.68	-296.61	-420.44	-61.86	-138.36
Free Cash Flow	-170.44	-200.62	-390.3	-988.73	-1,128
Free Cash Flow Margin	-521.50%	-4012.36%	-	-	-3294.09%
Free Cash Flow Per Share	-0.38	-0.47	-0.91	-2.63	-3.16
Cash Interest Paid	-	9.29	12.12	9.96	6.77
Cash Income Tax Paid	1.51	0.02	0.29	0.91	0.81
Levered Free Cash Flow	-72.98	-138.66	-36.72	-681.67	-895.55
Unlevered Free Cash Flow	-70.51	-132.86	-30.66	-676.55	-893.99
Change in Working Capital	-	-51.14	-96.48	-197.95	-284.59

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.